Company & Sponsor Intelligence
University of Plymouth
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting3
Completed1
Countries1
Therapeutic footprint
epilepsyocdparkinsonssubstance_use
Indexed studies
NCT06780501Neuropsychiatric Research Databases for People With Intellectual Disabilities and Epilepsy (REFINE)
epilepsy · United KingdomRECRUITING
epilepsy · United KingdomRECRUITING
NCT06722339Targeted Circuit-Based Transcranial Focused Ultrasound Intervention for Obsessive-Compulsive Disorder TUS-OCD
ocd · United KingdomNA
ocd · United KingdomNA
NCT04986020Identifying New Biomarkers of Parkinson's From Routine Brain Imaging
parkinsons · UNKNOWN
parkinsons · UNKNOWN
NCT06894966Towards a Targeted Ultrasound Neuromodulation Intervention for Alcohol Abuse Disorders
substance_use · United KingdomNA
substance_use · United KingdomNA
NCT05485428The HIIT-Home4Parkinson's Study
parkinsons · United KingdomNA
parkinsons · United KingdomNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →